Lilly Ups Legal Offensive Against Tirzepatide Copycats as FDA Mulls Shortage Status

Monday’s lawsuits from Eli Lilly are the first to be filed by the pharma since the regulator officially removed tirzepatide from its drug shortage database earlier this month.